Hooftman Leon bought BRNS
February 3, 2025 · Form 4 insider transaction
Hooftman Leon bought 140,000 shares of Barinthus Biotherapeutics plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
140,000
Price
$0.00
Total value
N/A
InsiderHooftman Leon
Role—
SecurityShare Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2025
Filing dateFebruary 5, 2025
Shares owned after140,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026.; The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.